首页 > 产品中心 > 有机化学

N-[2-[3-(1-哌嗪甲基)咪唑并[2,1-b]噻唑-6-基]苯基]-2-喹噁啉羧酰胺

SRT 1720

产品编号.: A434555 CAS号: 925434-55-5
分子式: C25H23N7Os 分子量: 469.56142
纯度: 99% MDL NO.:

中文名称：N-[2-[3-(1-哌嗪甲基)咪唑并[2,1-b]噻唑-6-基]苯基]-2-喹噁啉羧酰胺
CAS号：925434-55-5
中文别名：N-[2-[3-(1-哌嗪甲基)咪唑并[2,1-b]噻唑-6-基]苯基]-2-喹噁啉羧酰胺;3-(1-哌嗪基甲基)咪唑并[2,1-b]噻唑-6-基]苯基]-2-喹喔啉甲酰胺;N-[2-[3-(1-哌嗪基甲基)咪唑并[2,1-b]噻唑-6-基]苯基]-2-喹喔啉甲酰胺
英文名称：SRT 1720
英文别名：N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide;N-[2-[3-(1-piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-Quinoxalinecarboxamide;N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide;SRT1720;SRT-1720;SRT 1720;GTPL7703;HY-10532;NCGC00182052-03;SRT1720 - CAS 925434-55-5;SB19332;BCP13176;CHEMBL257991;NCGC00182052-06;EX-A033;UNII-DX3FHY76FZ;AC-35736;N-(2-(3-(1-Piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-2-quinoxalinecarboxamide;NCGC00182052-02;N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide;925435-64-9;F3390-0301;925434-55-5 (free base);CS-0437;AS-17063;IASPBORHOMBZMY-UHFFFAOYSA-N;Q7392863;EX-A7228;2-QUINOXALINECARBOXAMIDE, N-(2-(3-(1-PIPERAZINYLMETHYL)IMIDAZO(2,1-B)THIAZOL-6-YL)PHENYL)-;SRT-1720 free base;DX3FHY76FZ;AKOS016001425;Tafluprost enone;AMY36693;SCHEMBL963877;NCGC00182052-12;N-(2-{3-[(Piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide;BDBM50228363;N-{2-[3-(Piperazin-1-Ylmethyl)imidazo[2,1-B][1,3]thiazol-6-Yl]phenyl}quinoxaline-2-Carboxamide;NCGC00182052-01;J-690391;DTXSID00636045;925434-55-5;FT-0753807;BRD-K95926480-003-03-6;SRT1720?;DB-079335
EINEC:
分子式：C25H23N7OS
分子量：469.56142
搜索质检报告(COA)
搜索MSDS
相关产品

已经到最底了
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
© 2010-2025 郑州阿尔法化工有限公司  版权所有，并保留所有权利 豫ICP备19002673号-1 
技术支持：库价化学(KuuJia)
批量搜索 关闭
批处理可以通过CAS号，CAS号，每行一个搜索
...

N-[2-[3-(1-哌嗪甲基)咪唑并[2,1-b]噻唑-6-基]苯基]-2-喹噁啉羧酰胺
N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide;N-[2-[3-(1-piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-Quinoxalinecarboxamide;N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide;SRT1720;SRT-1720;SRT 1720;GTPL7703;HY-10532;NCGC00182052-03;SRT1720 - CAS 925434-55-5;SB19332;BCP13176;CHEMBL257991;NCGC00182052-06;EX-A033;UNII-DX3FHY76FZ;AC-35736;N-(2-(3-(1-Piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-2-quinoxalinecarboxamide;NCGC00182052-02;N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide;925435-64-9;F3390-0301;925434-55-5 (free base);CS-0437;AS-17063;IASPBORHOMBZMY-UHFFFAOYSA-N;Q7392863;EX-A7228;2-QUINOXALINECARBOXAMIDE, N-(2-(3-(1-PIPERAZINYLMETHYL)IMIDAZO(2,1-B)THIAZOL-6-YL)PHENYL)-;SRT-1720 free base;DX3FHY76FZ;AKOS016001425;Tafluprost enone;AMY36693;SCHEMBL963877;NCGC00182052-12;N-(2-{3-[(Piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide;BDBM50228363;N-{2-[3-(Piperazin-1-Ylmethyl)imidazo[2,1-B][1,3]thiazol-6-Yl]phenyl}quinoxaline-2-Carboxamide;NCGC00182052-01;J-690391;DTXSID00636045;925434-55-5;FT-0753807;BRD-K95926480-003-03-6;SRT1720?;DB-079335